Literature DB >> 12706093

Role of heparan sulfate for attachment and entry of tick-borne encephalitis virus.

Helga Kroschewski1, Steven L Allison, Franz X Heinz, Christian W Mandl.   

Abstract

Attachment of the flavivirus tick-borne encephalitis (TBE) virus to different permissive cell lines was investigated by a newly established quantitative assay using fluorescence-labeled virus. Previous work had shown that BHK-21 cell-adapted mutants of TBE virus had acquired potential heparan sulfate (HS) binding sites on the outer surface of protein E. Quantitative analysis of one of these mutants indicated that it attached to HS-expressing cell lines with a 10- to 13-fold higher affinity than wild-type TBE virus strain Neudoerfl. CHO cells deficient in HS synthesis bound less than 5% of the amount of wild-type or mutant virus that could attach to HS-containing CHO cells but were nevertheless found to be highly susceptible to infection with both viruses. Thus, even though HS is a major determinant of TBE virus attachment on HS-expressing cells, our findings suggest the existence of an alternative host cell receptor that is less abundant than HS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12706093     DOI: 10.1016/s0042-6822(02)00097-1

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  45 in total

Review 1.  Insight into a conserved lifestyle: protein-carbohydrate adhesion strategies of vector-borne pathogens.

Authors:  Rhoel R Dinglasan; Marcelo Jacobs-Lorena
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

2.  Construction and mutagenesis of an artificial bicistronic tick-borne encephalitis virus genome reveals an essential function of the second transmembrane region of protein e in flavivirus assembly.

Authors:  Klaus K Orlinger; Verena M Hoenninger; Regina M Kofler; Christian W Mandl
Journal:  J Virol       Date:  2006-10-11       Impact factor: 5.103

Review 3.  Learning from the viral journey: how to enter cells and how to overcome intracellular barriers to reach the nucleus.

Authors:  Diky Mudhakir; Hideyoshi Harashima
Journal:  AAPS J       Date:  2009-02-05       Impact factor: 4.009

4.  Interaction of Zika Virus Envelope Protein with Glycosaminoglycans.

Authors:  So Young Kim; Jing Zhao; Xinyue Liu; Keith Fraser; Lei Lin; Xing Zhang; Fuming Zhang; Jonathan S Dordick; Robert J Linhardt
Journal:  Biochemistry       Date:  2017-02-13       Impact factor: 3.162

5.  Changing the protease specificity for activation of a flavivirus, tick-borne encephalitis virus.

Authors:  Wolfgang Fischl; Sigrid Elshuber; Sabrina Schrauf; Christian W Mandl
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

Review 6.  Closing the door on flaviviruses: entry as a target for antiviral drug design.

Authors:  Rushika Perera; Mansoora Khaliq; Richard J Kuhn
Journal:  Antiviral Res       Date:  2008-06-11       Impact factor: 5.970

7.  Common E protein determinants for attenuation of glycosaminoglycan-binding variants of Japanese encephalitis and West Nile viruses.

Authors:  Eva Lee; Roy A Hall; Mario Lobigs
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

8.  The hypervariable region 1 of the E2 glycoprotein of hepatitis C virus binds to glycosaminoglycans, but this binding does not lead to infection in a pseudotype system.

Authors:  Arnab Basu; Aster Beyene; Keith Meyer; Ranjit Ray
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

9.  Rapid accumulation of virulent rift valley Fever virus in mice from an attenuated virus carrying a single nucleotide substitution in the m RNA.

Authors:  John C Morrill; Tetsuro Ikegami; Naoko Yoshikawa-Iwata; Nandadeva Lokugamage; Sungyong Won; Kaori Terasaki; Aya Zamoto-Niikura; C J Peters; Shinji Makino
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

10.  Extension of flavivirus protein C differentially affects early RNA synthesis and growth in mammalian and arthropod host cells.

Authors:  Sabrina Schrauf; Christian W Mandl; Lesley Bell-Sakyi; Tim Skern
Journal:  J Virol       Date:  2009-08-19       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.